7-Aug-2026
UBS Sticks to Its Buy Rating for McKesson (MCK)
TipRanks (Thu, 6-Aug 8:08 AM ET)
TipRanks (Thu, 6-Aug 8:06 AM ET)
Bank of America Securities Reaffirms Their Buy Rating on McKesson (MCK)
TipRanks (Thu, 6-Aug 7:59 AM ET)
Barclays Sticks to Its Buy Rating for McKesson (MCK)
TipRanks (Thu, 6-Aug 4:37 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Wed, 5-Aug 11:00 PM ET)
TipRanks (Wed, 5-Aug 7:10 PM ET)
McKesson raises 2026 profit outlook as FQ1 beats on both lines
Seeking Alpha News (Wed, 5-Aug 6:14 PM ET)
McKesson Non-GAAP EPS of $9.93 beats by $0.39, revenue of $105.38B beats by $1.64B
Seeking Alpha News (Wed, 5-Aug 4:51 PM ET)
McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance
Business Wire (Wed, 5-Aug 4:10 PM ET)
McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share
Business Wire (Wed, 22-Jul 8:00 AM ET)
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Mckesson trades on the NYSE stock market under the symbol MCK.
As of August 7, 2026, MCK stock price declined to $869.58 with 1,350,063 million shares trading.
MCK has a beta of -0.19, meaning it tends to be less sensitive to market movements. MCK has a correlation of 0.01 to the broad based SPY ETF.
MCK has a market cap of $101.38 billion. This is considered a Large Cap stock.
Last quarter Mckesson reported $105 billion in Revenue and $9.93 earnings per share. This beat revenue expectation by $1 billion and exceeded earnings estimates by $.31.
In the last 3 years, MCK traded as high as $999.00 and as low as $404.72.
The top ETF exchange traded funds that MCK belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
MCK has outperformed the market in the last year with a return of +31.6%, while the SPY ETF gained +23.5%. In the last 3 month period, MCK beat the market returning +15.3%, while SPY returned +6.0%. However, in the most recent 2 weeks MCK has underperformed the stock market by returning +3.4%, while SPY returned +4.6%.
MCK support price is $850.78 and resistance is $891.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MCK shares will trade within this expected range on the day.
